RxDoctor Payments Data

Rahn Ravenell, DPM

Foot & Ankle Surgery · Charleston, SCNPI 1639492473

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,364 of the $51,487 with a category attached, or 68.7%. 33 manufacturers reported payments, led by Geistlich Pharma, North America, Inc. at 53.8% of the total. Reporting peaked in 2021 at $16,456 and has fallen 70.7% since, to $4,818 in 2025.

$51,487in general payments, 2019–2025

Across 152 payments — averaging $338.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Geistlich Pharma, North America, Inc.$28K
  • Stryker$6K
  • Darco International, Inc.$5K
  • Integra Lifesciences Corporation$4K
  • Kerecis Limited$2K
  • Peerless Surgical Inc.$2K
  • plus $5K from 27 others

What the payments were for

  • Consulting fees$35,36469%
  • Speaking & faculty fees$5001%
  • Travel & lodging$1,5153%
  • Food & beverage$11,97523%
  • Education$2,1334%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,487 in reported general payments places this provider in the 85th percentile of 87 foot & ankle surgery providers in South Carolina.

See all foot & ankle surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$170,735
Medicare patients
753
Services billed
5,673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox32$844
Ammonium Lactate42$843
Gabapentin88$767
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen61$576
Celecoxib20$530
Terbinafine Hcl44$405
Mupirocin49$371
Ondansetron Hcl67$311
Doxycycline Hyclate23$288
Pregabalin33$276
Cephalexin47$211
Prednisone14$194
Meloxicam30$89
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$65
Allopurinol11$60

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →